Literature DB >> 20440380

In vitro assays of inorganic arsenic methylation.

Zuzana Drobna1, Miroslav Styblo, David J Thomas.   

Abstract

Inorganic arsenic is extensively metabolized to produce mono-, di-, and trimethylated products. The formation of these metabolites produces a variety of intermediates that differ from inorganic arsenic in terms of patterns of distribution and retention and in toxic effects. In order to elucidate the pathway for arsenic methylation, it was necessary to develop a reliable in vitro assay system in which the formation of methylated metabolites could be monitored. Here, in vitro assay system that uses the postmicrosomal supernate from rat liver is used as the source of the enzymatic activity that catalyzes methylation reactions. This system can be used to study the requirements for methylation reactions (e.g., identifying the donor of methyl groups) and for screening of compounds as potential activators or inhibitors of arsenic methylation.

Entities:  

Keywords:  arsenic; methylated arsenicals; methylation reactions; postmicrosomal fraction; rat liver

Mesh:

Substances:

Year:  2009        PMID: 20440380      PMCID: PMC2862005          DOI: 10.1002/0471140856.tx0432s42

Source DB:  PubMed          Journal:  Curr Protoc Toxicol        ISSN: 1934-9254


  11 in total

1.  The biomethylation of sodium arsenate by rat liver cytosol determined by mass spectrometry.

Authors:  M S Smith; P R Jones; D Y Shirachi
Journal:  Proc West Pharmacol Soc       Date:  1992

2.  Binding of dimethylarsinous acid to cys-13alpha of rat hemoglobin is responsible for the retention of arsenic in rat blood.

Authors:  Meiling Lu; Hailin Wang; Xing-Fang Li; Lora L Arnold; Samuel M Cohen; X Chris Le
Journal:  Chem Res Toxicol       Date:  2007-01       Impact factor: 3.739

3.  Preparation and purification of 74As-labeled arsenate and arsenite for use in biological experiments.

Authors:  P F Reay; C J Asher
Journal:  Anal Biochem       Date:  1977-04       Impact factor: 3.365

4.  Binding of arsenicals to proteins in an in vitro methylation system.

Authors:  M Styblo; D J Thomas
Journal:  Toxicol Appl Pharmacol       Date:  1997-11       Impact factor: 4.219

5.  Evidence of hemoglobin binding to arsenic as a basis for the accumulation of arsenic in rat blood.

Authors:  Meiling Lu; Hailin Wang; Xing-Fang Li; Xiufen Lu; William R Cullen; Lora L Arnold; Samuel M Cohen; X Chris Le
Journal:  Chem Res Toxicol       Date:  2004-12       Impact factor: 3.739

6.  Study of factors influencing the in vivo methylation of inorganic arsenic in rats.

Authors:  J P Buchet; R Lauwerys
Journal:  Toxicol Appl Pharmacol       Date:  1987-10       Impact factor: 4.219

7.  Mono- and dimethylation of arsenic in rat liver cytosol in vitro.

Authors:  M Styblo; M Delnomdedieu; D J Thomas
Journal:  Chem Biol Interact       Date:  1996-01-05       Impact factor: 5.192

8.  Comparative in vitro methylation of trivalent and pentavalent arsenicals.

Authors:  M Styblo; H Yamauchi; D J Thomas
Journal:  Toxicol Appl Pharmacol       Date:  1995-12       Impact factor: 4.219

9.  Study of inorganic arsenic methylation by rat liver in vitro: relevance for the interpretation of observations in man.

Authors:  J P Buchet; R Lauwerys
Journal:  Arch Toxicol       Date:  1985-06       Impact factor: 5.153

10.  Endogenous reductants support the catalytic function of recombinant rat cyt19, an arsenic methyltransferase.

Authors:  Stephen B Waters; Vicenta Devesa; Luz Maria Del Razo; Miroslav Styblo; David J Thomas
Journal:  Chem Res Toxicol       Date:  2004-03       Impact factor: 3.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.